日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Need for an external proficiency testing program for cytokines, chemokines, and plasma markers of immune activation.

需要建立细胞因子、趋化因子和免疫激活血浆标志物的外部能力验证计划

Fahey J L, Aziz N, Spritzler J, Plaeger S, Nishanian P, Lathey J L, Seigel J, Landay A L, Kilarui R, Schmitz J L, White C, Wara D W, Akridge R, Cutili J, Douglas S D, Reuben J, Shearer W T, Nokta M, Polland R, Schooley R, Asthana D, Mizrachi Y, Waxdal M

Variables that affect assays for plasma cytokines and soluble activation markers

影响血浆细胞因子和可溶性激活标志物检测的变量

Aziz, N; Nishanian, P; Mitsuyasu, R; Detels, R; Fahey, J L

Cytokine gene expression in normal human lymphocytes in response to stimulation

正常人淋巴细胞在受到刺激后细胞因子基因的表达

Fan, J; Nishanian, P; Breen, E C; McDonald, M; Fahey, J L

Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures

人类免疫缺陷病毒感染患者血浆中细胞因子和免疫激活标志物的水平:质量控制程序

Aziz, N; Nishanian, P; Fahey, J L

Oral fluids as an alternative to serum for measurement of markers of immune activation

口腔液可作为血清的替代样本用于测量免疫激活标志物。

Nishanian, P; Aziz, N; Chung, J; Detels, R; Fahey, J L

Different lymphoid cell populations produce varied levels of neopterin, beta 2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumour necrosis factor-alpha

不同的淋巴细胞群在受到IL-2、干扰素-γ或肿瘤坏死因子-α刺激时,会产生不同水平的新蝶呤、β2-微球蛋白和可溶性IL-2受体。

Hofmann, B; Bass, H; Nishanian, P; Faisal, M; Figlin, R A; Sarna, G P; Fahey, J L

Detection of early antibodies in human immunodeficiency virus infection by enzyme-linked immunosorbent assay, Western blot, and radioimmunoprecipitation

利用酶联免疫吸附试验、蛋白质印迹法和放射免疫沉淀法检测人类免疫缺陷病毒感染早期抗体

Saah, A J; Farzadegan, H; Fox, R; Nishanian, P; Rinaldo, C R Jr; Phair, J P; Fahey, J L; Lee, T H; Polk, B F